Pune, Dec. 06, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled, “Brachytherapy Market by Product (Seeds, Brachytherapy After Loaders, Brachytherapy Applicators [Intraluminal Applicators, Interstitial Applicators, Intraoperative and Surface Applicators], and Electronic Brachytherapy), Dosage Type/Techniques (High Dosage Rate (HDR) Brachytherapy, Low Dosage Rate (LDR) Brachytherapy, Medium Dosage rate (MDR) Brachytherapy, Ultra-Low Dosage Rate Brachytherapy, Pulse Dosage Rate (PDR) Brachytherapy, and Image Guided Brachytherapy) Application (Gynecological Cancer, Prostate Cancer, Anal/Rectal Cancer, Breast Cancer, and Esophageal Cancer), and End User (Hospitals, Oncology Treatment Centers, Specialty Clinics, Clinical Laboratories, & Academic and Medical Centers) – Global Outlook & Forecast 2022-2030" published by Growth Plus Reports, the brachytherapy market is expected to grow at a CAGR of 7.95% from 2021 to reach US$ 1.78 billion by 2030. Brachytherapy is emerging as a promising therapy option for COVID-19 patients helping increase their immunity.
Download PDF Brochure of Brachytherapy Market Size - COVID-19 Impact and Global Analysis with Strategic Developments at: https://growthplusreports.com/inquiry/request-sample/brachytherapy-market/8011
The global brachytherapy market has been analysed from four different perspectives – product, dosage type/technique, application, end user and region
Excerpts from ‘By Product Segmentation’
The brachytherapy market has been divided into:
Brachytherapy After Loaders
Based on by product segment. The brachytherapy applicators are further sub-segmented into intraluminal applicators, interstitial applicators, intraoperative and surface applicators. Due to the growing usage of brachytherapy applicators in the treatment of gynaecological malignancies and other cancers to lessen radiation exposure to nearby healthy tissues and organs, brachytherapy applicator sector is predicted to have showcase high revenue growth over the forecast period. Medical imaging also helps with correct positioning of the applicators to treat tumours efficiently. Applicators help direct where the treatment is to be delivered. To administer more exact dosages during cancer brachytherapy, a wide variety of applicators are offered on the market for use in a variety of treatments.
Inquiry Before Buying: https://growthplusreports.com/inquiry/before-buying/brachytherapy-market/8011
Excerpts from ‘By Dosage type/ Technique Segmentation’
The market for brachytherapy is segmented into:
High Dose Rate (HDR)
Low Dosage Rate (LDR)
Medium Dosage Rate (MDR)
Ultra-Low Dosage Rate (ULDR)
Pulse Dosage Rate (PDR)
Image Guided Brachytherapy
Based on dosage type or techniques employed. Over the course of the forecast period, HDR was shown to have the highest revenue share in the global brachytherapy market. In HDR brachytherapy, a catheter is momentarily inserted into the tumor's vicinity by a radiation source. The treatment enables the brief implantation of radioactive material to kill unwanted or potentially hazardous cells inside the body. For the treatment of several types of cancer, including skin, cervical, prostate, head and neck, and breast cancer, the therapy is typically carried out as an outpatient procedure. The short process duration, higher efficacy, and radiation protection are some of the elements influencing this segment's supremacy. Around the world, HDR afterloaders are progressively replacing LDR afterloaders because most manufacturers no longer promise to maintain LDR systems. Furthermore, HDR brachytherapy is performed as an outpatient procedure, which increases its usefulness and affordability.
Excerpts from ‘By Application Segmentation’
Based on the applications, the global brachytherapy market is classified for:
Treating Cancers Of The Gynaecological System
The Anal/Rectal System
According to reports, the global market for brachytherapy is dominated by the prostate cancer, which generates the biggest income share. Brachytherapy is a viable treatment option for all individuals with confined prostate cancer development, both by itself and in conjunction with outer bar radiation therapy. The promising uses of brachytherapy for the treatment of prostate cancer in 2021 where the factors driving this segment. Low-dose rate brachytherapy has emerged as a common therapeutic modality for prostate cancer due to its unmatched long-term therapeutic efficacy in every risk group. Brachytherapy is frequently utilized alone to perform preventive prostate cancer that is slowly developing. Furthermore, it was noted that the application category for breast cancer brachytherapy will see a sizable CAGR over the course of the forecast period.
Excerpts from ‘By Region Segmentation’
The global brachytherapy market has been divided into:
Rest of the world
Due to its rapidly developing healthcare infrastructure and rising healthcare spending, North America dominated the global market in 2021. The growth is being driven by an ageing population and rising cancer prevalence. Rapid advancements in radiation oncology, a rising prevalence of prostate and breast cancer, the availability of cutting-edge healthcare facilities and qualified professionals, favourable reimbursement policies, and the presence of important corporations in the area are just a few of the factors contributing to the rising use of brachytherapy for the treatment and prevention of malignant and non-malignant diseases. Due to rising cancer rates, extensive R&D efforts in the healthcare industry, increased ease of access to advanced technological cancer treatment and control approaches, rising public awareness of the advantages of early-stage cancer treatment, and an increase in international collaborations among companies, the North American market revenue is anticipated to grow during the forecast period. For instance, in January 2022 American Cancer Society updated that, about 2,710 new cases of invasive breast cancer are expected to be diagnosed by the end of 2022.
Excerpts from ‘Competitive landscape’
A few of the top businesses operating brachytherapy market are:
Eckert & Ziegler BEBIG S.A.
Varian Medical Systems, Inc.
Sun Nuclear Corporation
CIVCO Medical Solutions
Argon Medical Devices, Inc.
C.R. Bard Inc.
Huiheng Medical Inc.
Isoray Medical Inc.
Becton, Dickinson & Company
Carl Zeiss Meditec AG
Bard Medical Division
Best Medical International, Inc.
Table of Content
GLOBAL BRACHYTHERAPY MARKET - ANALYSIS & FORECAST, BY PRODUCT
GLOBAL BRACHYTHERAPY MARKET - ANALYSIS & FORECAST, BY DOSAGE TYPE / TECHNIQUES
GLOBAL BRACHYTHERAPY MARKET - ANALYSIS & FORECAST, BY APPLICATION
VALUE PROPOSITIONS RELATED TO THE REPORT:
Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Blanket coverage on competitive landscape
Exhaustive coverage on 'Strategic Developments' registered by leading players of the market
Distributor Landscape Assessment
Customer Base Assessment
Investment & Initiatives Analysis
'Business Profile' of Key Players
Purchase this exclusive report now: https://growthplusreports.com/checkout?_token=GqsHTeo872CP3NN6BKUe9RB4q8AvpFOLZeAflI4L&report_id=8011&license=Single
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.
CONTACT: Manan Sethi Director, Market Insights Email: email@example.com Phone no: +91 96545 76783 Web: https://growthplusreports.com/ Follow Us: LinkedIn | Twitter